SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Plethico Pharmaceuticals
BSE: 532739|NSE: PLETHICO|ISIN: INE491H01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 22, 16:15
40.50
-0.3 (-0.74%)
VOLUME 8,561
LIVE
NSE
Oct 22, 16:15
40.60
-0.1 (-0.25%)
VOLUME 11,860
Announcements on Plethico Pharma

21st-Oct-2014 15:37Source: BSE

Plethico Pharma- Shareholding Pattern For September 30, 2014

Plethico Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014.

10th-Sep-2014 11:57Source: BSE

Plethico Pharma- Outcome of Board Meeting

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 09, 2014, inter- alia, decided to postpone its 21st Annual General Meeting (AG...

9th-Sep-2014 20:09Source: NSE

Plethico Pharmaceuticals Limited

Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on September 09, 2014, inter-alia, decided to postpone its Annual General Me...

9th-Sep-2014 14:15Source: BSE

Plethico Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

8th-Sep-2014 15:53Source: BSE

Plethico Pharma- Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shashikant Patel has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

8th-Sep-2014 15:45Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant A Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Aug-2014 19:00Source: BSE

Plethico Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Plethico Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

27th-Aug-2014 15:10Source: BSE

Plethico Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Shashikant Patel has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Aug-2014 15:04Source: BSE

Plethico Pharma- Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Shashikant Patel has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

13th-Aug-2014 23:33Source: BSE

Plethico Pharma- Outcome of Board Meeting (AGM on Sept 29, 2014)

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2014, inter alia, has considered the following:

1. Fixing September 29...

1 2 3 4 5 Next >>
Quick Links for Plethico Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.